Clin2
NCT06655376Possibly a fitRecruiting

Aspirin study for advanced heart failure with a heart pump

BleedingClot Blood

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests if taking aspirin along with a standard blood thinner helps people with a HeartMate3 heart pump have fewer bleeding or clotting problems. It is for people who have had their pump for at least 3 months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
128 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a HeartMate3 left ventricular assist device (LVAD) that was placed more than 3 months ago.
  • You are 18 years old or older.
  • You are currently taking aspirin and a vitamin K antagonist (VKA) blood thinner (like warfarin).
  • You are not pregnant and use appropriate birth control if needed.
  • You are not taking any other antiplatelet medicines (like clopidogrel) for other conditions.
  • You are not in another study that might affect this trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07644247Not yet recruiting· Phase 4
Aspirin removal in patients with a CH-VAD heart pump

This study tests whether it is safe to stop taking aspirin after getting a CH-VAD heart pump, which helps pump blood for people with advanced heart failure. If you are taking aspirin to prevent blood clots, this trial will help doctors learn if you can stop it.

NCT07471139Not yet recruiting· Phase 3
Apixaban vs warfarin for heart pump patients

This study compares two blood thinners for people who have a HeartMate 3 left ventricular assist device (LVAD). The goal is to see if the newer medicine, apixaban, works better or has fewer side effects than the standard medicine, warfarin.

NCT07796217Recruiting· Phase 4
Comparing blood thinners after a heart attack

This study compares two ways to lower the chances of another heart attack: taking the standard medicine (clopidogrel) versus taking a combination of aspirin and a lower dose of a blood thinner (rivaroxaban). If you join, you'll be assigned to one of these options to see which works better for people like you.

Seongnam-si, Gyeonggi-do
NCT04045665Recruiting· Phase 3
Blood thinner vs usual care for new heart rhythm after bypass surgery

This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.

Little Rock, Arkansas
NCT07081035Not yet recruiting· Phase 4
Lower dose blood thinners for heart pump patients

This study tests whether a lower dose of blood thinners can reduce bleeding problems while still preventing blood clots in people who have a HeartMate 3 heart pump. If you are stable on your current blood thinner, this trial might help you avoid serious bleeding complications.

Seoul
NCT05347069Recruiting· Phase 4
Aspirin study for people with stable heart artery disease

This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.

Kyoto

Hear when a new Bleeding trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.